Radioactive "Seed" Implants May Rival Surgery for Low-Risk Prostate Cancer Patients

Avoiding surgery in prostate cancer patients with low-risk disease

10.2217/14750708.5.1.25 © 20 At present, the treatment paradigm for localized prostate cancer (PCa) is to distinguish patients with clinically relevant cancers who require treatment either in the form of traditional radical therapy or a contemporary less aggressive, organ-preserving approach, from the remainder who do not need any intervention at the time of diagnosis. Recent research has propo...

The path to quality prostate seed implants.

© The Canadian Journal of UrologyTM; 20(5); October 2013 Address correspondence to Dr. Timothy N. Showalter, Department of Radiation Oncology, University of Virginia School of Medicine, 1215 Lee Street, Box 800383, Charlottesville, VA 22908 USA The path to quality prostate seed implants Xinglei Shen, MD,1 Timothy N. Showalter, MD2 1Department of Radiation Oncology, University of Kansas Cancer M...

Active Surveillance For Low Risk Prostate Cancer

Active surveillance for low-risk prostate cancer

During the last decades, incidence of prostate cancer has increased at the expense of cases at low-risk of progression. Meanwhile, the concept of active surveillance has gained widespread acceptance in order to decease the risk of overtreatment. Active surveillance is based on a strict patient monitoring to detect potential disease progression and to propose on time a radical differed treatment...

Prophylactic urethral stenting with Memokath® 028SW in prostate cancer patients undergoing prostate 125I seed implants: phase I/II study

PURPOSE To study the feasibility/toxicity of urethral stenting with the Memokath® 028SW stent in patients undergoing prostate implant (PI) for prostate adenocarcinoma. MATERIAL AND METHODS An Investigational Device Exemption from the Food and Drug Administration (FDA) and institutional review board (IRB) approval were obtained. Twenty patients enrolled. Baseline American Urological Associatio...